Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: J Nucl Cardiol. 2018 Jul 26;27(5):1486–1496. doi: 10.1007/s12350-018-1376-7

Table 3.

Myocardial SPECT Imaging Results Versus Exercise Capacity in Patients Achieving ≥85% of Their MAPHR.

Characteristic <7 METS*
Achieved
(n= 93)
7-9 METS
Achieved
(n= 192)
≥10 METS
Achieved
(n= 97)
P-value
Perfusion
 Fixed Perfusion Defects 27 (29.0) 30 (15.6) 12 (12.4) 0.005δ
 Any Reversible Ischemia 32 (34.4) 42 (21.9) 13 (13.4) 0.002
 Percentage LV Ischemia (mean ± SD) 2.7±5.2 1.7±4.3 0.9±3.1
 LV Ischemic burden 0.037
   0% Ischemic 61 (65.6) 150 (78.1) 84 (86.6)
  1-4% Ischemic 13 (14.0) 18 (9.4) 7 (7.2)
  5-9% Ischemic 8 (8.6) 13 (6.8) 3 (3.1)
  ≥10% Ischemic 11 (11.8) 11 (5.7) 3 (3.1)
Volumes & Function
 ESVI* (median (25th, 75th percentiles) 12 (9, 20) 11 (8, 17) 15 (11, 19) 0.07
  ESVI ≥25 14 (15.2) 19 (10.1) 12 (12.5) 0.45
 EDVI* 45 (38, 55) 43 (38, 51) 46 (39, 56) 0.053
 Ejection fraction 65 (57, 69) 65 (59, 71) 63 (58, 68) 0.07
*

EDVI=end-diastolic volume index; ESVI=end-systolic volume index; METS=metabolic equivalents.

All fixed perfusion defects had either known prior infarction in the affected territory or an associated wall-motion abnormality.

δ

P-values are two-tailed with values <0.05 considered statistically-significant.